/
/
Publicaties

Publicaties

Onze specialisten werken geregeld mee aan wetenschappelijke onderzoeken. Met trots delen we deze publicaties.

Filter op:

juni 2026

Concomitant MRI-detected and MRI-undetected prostate cancer with implications for biopsy strategies and focal therapy planning: an analysis of the PROMIS and PICTURE trials

dr. M. Peters

juni 2026

No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinoma

M.A.D. Haverkort

mei 2026

Twenty-year results of the randomized European organization for research and treatment of cancer trial 22922/10925 evaluating internal mammary chain and medial supraclavicular lymph node irradiation in stage I-III breast cancer

dr. M. Peters

mei 2026

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial

dr. ir. D. Schuring

mei 2026

A national, multicentre, randomised, controlled, parallel-arms, phase III clinical trial of neoadjuvant FOLFOXIRI and chemoradiotherapy versus neoadjuvant CAPOX/FOLFOX and chemoradiotherapy in patients with high-risk locally advanced rectal cancer: study protocol of the MEND-IT II trial

dr. M.D. den Hartogh

mei 2026

The challenge of informed consent: Propensity score weighting to prevent selection bias

dr. M.D. den Hartogh

mei 2026

Prediction of pneumonia following neoadjuvant chemoradiotherapy in patients with oesophageal cancer

dr. M.D. den Hartogh

april 2026

Local salvage therapy alone for local recurrence of prostate cancer after radiotherapy

M. Rasing

dr. M. Peters

april 2026

Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer – PORTEC-4a an international, randomised, phase 3 trial

M.A.D. Haverkort

april 2026

Local control in oligometastatic cancer patients following metastasis-directed stereotactic ablative radiotherapy: An interim analysis of ESTRO EORTC E2-RADIatE OligoCare cohort

dr. P.M. Jeene

april 2026

Updated Dutch guideline for management of radiation oncology patients with a pacemaker, implantable cardioverter defibrillator or non-cardiac active implant

dr. ir. W.P.A. Jansen

april 2026

Outcomes after (chemo)radiotherapy for anal cancer – A nationwide cohort study

dr. K. Muller

maart 2026

In their own words: A qualitative study of patient narratives on daily life after breast cancer radiotherapy

M.R. Stam

maart 2026

Cardiovascular disease risk after radiotherapy and anthracycline-based chemotherapy for diffuse large B-cell lymphoma

dr. K. Muller

E.C. Schimmel

maart 2026

Predicting long-term absolute risk of lung cancer in Hodgkin lymphoma patients

dr. K. Muller

E.C. Schimmel

maart 2026

The complication sum score: A Delphi-based approach to summarize treatment related complications for esophageal cancer

dr. M.D. den Hartogh

maart 2026

Health-related quality of life after definitive chemoradiotherapy in patients with esophageal carcinoma: a population-based analysis

dr. P.M. Jeene

februari 2026

Pretreatment risk model for radiation-induced lymphopenia is associated with adjuvant durvalumab efficacy in patients with unresectable stage III NSCLC

dr. M. Peters

februari 2026

X-ray beam quality checks of a magnetic resonance-guided linear accelerator with its on-board megavoltage imager

dr. ir. A.W.H. Minken

G. Hilgers

februari 2026

Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)

G. Wester

februari 2026

Nomogram-based risk classification for predicting response to metastasis-directed stereotactic body radiotherapy in PSMA PET-staged oligorecurrent prostate cancer (PORTAL): an international, retrospective cohort study

dr. M. Peters

februari 2026

Salvage focal therapy vs radical prostatectomy for localized radiorecurrent prostate cancer

dr. M. Peters

januari 2026

Molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer (PORTEC-4a): results of a randomised, open-label, phase 3, multicentre, non-inferiority trial

M.A.D. Haverkort

december 2025

Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancer.

M.A.D. Haverkort

november 2025

Oncological outcomes of planned and unplanned low Hartmann’s procedure and restorative low anterior resection for rectal cancer: a population-based cross-sectional study

Dutch Snapshot Research Group

november 2025

Treatment and survival of patients with esophageal and gastric cancer in the Netherlands and Belgium: a population-based comparison.

dr. P.M. Jeene

oktober 2025

Clinical nodal staging to assess the risk of local recurrence after rectal cancer resection: A nationwide cross-sectional study

Dutch Snapshot Research Group

oktober 2025

A goal without a plan is just a wish-creating a personalized aftercare plan for breast cancer patients supported by the breast cancer aftercare decision aid.

dr. M. van Hezewijk

oktober 2025

Dose de-escalation of elective neck irradiation in head and neck cancer: a secondary analysis of acute toxicity findings from the randomized controlled UPGRADE-RT trial.

dr. B. Kreike

oktober 2025

A multi-centre evaluation of deep learning based radiotherapy planning for left-sided node-negative breast cancer.

dr. ir. R.G.J. Kierkels

september 2025

Radiation Pneumonitis.

dr. P.M. Jeene

dr. M. Peters

september 2025

National indication protocol for proton radiotherapy in esophageal cancer patients in the Netherlands.

dr. K. Muller

juli 2025

Reporting breast cancer radiation therapy details in studies and daily practice: Nice-to-have or a must-have?

M.R. Stam

juli 2025

Increased incidence of primary metastatic prostate cancer in the era of PSMA PET/CT: a population-based analysis.

dr. M. Peters

juni 2025

Salvageable locoregional recurrence and stoma rate after local excision of pT1-2 rectal cancer – A nationwide cross-sectional cohort study

Dutch Snapshot Research Group

juni 2025

Decision making about localized esophageal cancer treatment: An observational study on variation in clinicians’ communication behavior.

dr. P.M. Jeene

juni 2025

Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020-2023, using registry data and questionnaires.

M.R. Stam

juni 2025

Incomplete neoadjuvant chemo(radio)therapy negatively impacts pathological response and overall survival in locally advanced esophageal cancer.

dr. P.M. Jeene

mei 2025

Feasibility and clinical potential of exercise interventions during neoadjuvant chemoradiotherapy in patients with esophageal and rectal cancer.

dr. M.D. den Hartogh

mei 2025

Distant metastasis after chemoradiation and image guided adaptive brachytherapy in locally advanced cervical cancer.

M.A.D. Haverkort

mei 2025

Beam modeling and validation for a 1.5 T MR-linac in an alternative treatment planning system.

dr. ir. A.W.H. Minken

dr. ir. R.G.J. Kierkels

Guido Hilgers

april 2025

Three-year patient-reported outcomes of the BOOG 2013-08 RCT evaluating omission of sentinel lymph node biopsy in early-stage breast cancer patients treated with breast conserving surgery: impact of personality traits on health-related quality of life.

Helen Westenberg

april 2025

Multidisciplinary approach to target volume delineation in locally recurrent rectal cancer: an explorative study.

dr. M.D. den Hartogh

april 2025

Postoperative radiotherapy for oral cavity cancer with or without elective neck radiotherapy of the pN0 en bloc dissected neck: oncologic outcomes and late toxicity.

dr. B. Kreike

april 2025

Clinical benefit and safety of reduced elective dose in definitive radiotherapy for head and neck squamous cell carcinoma: the UPGRADE-RT multicenter randomized controlled trial.

dr. B. Kreike

maart 2025

Different needs ask for different care: Breast cancer patients’ preferences regarding assessment of care needs and information provision in personalized aftercare.

NABOR project group

maart 2025

Gross tumor volume increase and need for adaptive radiotherapy in pediatric-type diffuse high-grade glioma of the midline structures.

dr. M. Peters

februari 2025

Variations in radiation therapy delineation of the lateral compartments in patients with rectal cancer: results after an updated national guideline

Dutch Lateral Compartment Delineation Group

januari 2025

Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions

dr. M. Peters

januari 2025

Salvageable locoregional recurrence and stoma rate after local excision of pT1-2 rectal cancer – a nationwide cross-sectional cohort study.

Collaborators Snapshot Registry

januari 2025

The added value of physical examination for breast cancer recurrence detection in women: a systematic review.

dr. M. van Hezewijk

januari 2025

Pandemic driven preoperative moderate hypofractionated radiotherapy for soft tissue sarcomas.

dr. M. van Hezewijk

januari 2025

Defining the optimal radiation-induced lymphopenia metric to discern its survival impact in esophageal cancer.

dr. M. Peters

december 2024

Clinical Introduction of Stem Cell Sparing Radiotherapy to Reduce the Risk of Xerostomia in Patients with Head and Neck Cancer

A.S. Arents-Huls

december 2024

Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial

M.A.D. Haverkort

december 2024

Cost-effectiveness of a nurse-led sexual rehabilitation intervention for women treated with radiotherapy for gynaecological cancer in a randomized trial.

M.A.D. Haverkort

november 2024

Retinoblastoma Protein Loss in p53 Abnormal Endometrial Carcinoma: Histologic and Clinicopathological Correlates

M.A.D. Haverkort

november 2024

Retinoblastoma protein loss in p53 abnormal endometrial carcinoma: histologic and clinicopathological correlates.

M.A.D. Haverkort

november 2024

Ten-year survival after postmastectomy chest-wall irradiation in breast cancer.

A.H. Westenberg

oktober 2024

Optimised treatment of patients with enlarged la teral lymph no des in re ctal cancer: protocol of an international, multicentre, prospective registration study after extensive multidisciplinary training (LaNoReC)

LaNoReC study group

oktober 2024

Locoregional control in high-risk neuroblastoma using highly-conformal image-guided radiotherapy, with reduced margins and a boost dose for residual lesions

dr. M. Peters

oktober 2024

The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy

dr. M. van Hezewijk

oktober 2024

Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort

dr. P.M. Jeene

oktober 2024

The INFLUENCE 3.0 model: updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.

dr. M. van Hezewijk

september 2024

Association Between the Regular Use of Vaginal Dilators and/or Sexual Activity and Vaginal Morbidity in Locally Advanced Cervical Cancer Survivors: An EMBRACE-I Study Report

E. Van der Steen-Banasik

september 2024

The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies

dr. M. Peters

september 2024

The EORTC 22922/10925 trial investigating regional nodal irradiation in stage I-III breast cancer: Outcomes according to locoregional and systemic therapies

dr. M. Peters

september 2024

Association between the regular use of vaginal dilators and/or sexual activity and vaginal morbidity in locally advanced cervical cancer survivors: an EMBRACE-I Study report.

Elzbieta Van der Steen-Banasik

augustus 2024

Robotic MR-guided high dose rate brachytherapy needle implantation in the prostate (ROBiNSon)-a proof-of-concept study

M. Rasing

dr. M. Peters

juli 2024

Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy

dr. M. Peters

C.J.A. Tissing-Tan

juli 2024

Implementation of ultra-hypofractionated radiotherapy schedules for breast cancer during the COVID-19 pandemic in the Netherlands

M.R. Stam

juli 2024

Efficacy of a nurse-led sexual rehabilitation intervention for women with gynaecological cancers receiving radiotherapy: results of a randomised trial

M.A.D. Haverkort

juni 2024

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

dr. K. Muller

E.C. Schimmel

juni 2024

Cancer-specific dose and fractionation schedules in stereotactic body radiotherapy for oligometastatic disease: An interim analysis of the EORTC-ESTRO E2-RADIatE OligoCare study

dr. P.M. Jeene

juni 2024

European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4)

dr. P.M. Jeene

mei 2024

Long-term restoration of bowel continuity after rectal cancer resection and the influence of surgical technique: A nationwide cross-sectional study

Dutch Snapshot Research Group

mei 2024

The optimal treatment for patients with stage I non-small cell lung cancer: minimally invasive lobectomy versus stereotactic ablative radiotherapy – a nationwide cohort study

ESLUNG group

april 2024

Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit

Participants of the Dutch Gynecological Oncology Audit Collaborator Group

april 2024

Impact of the new rectal cancer definition on multimodality treatment and interhospital variability: Results from a nationwide cross-sectional study

Dutch Snapshot Research Group

april 2024

Prognostic impact and causality of age on oncological outcomes in women with endometrial cancer: a multimethod analysis of the randomised PORTEC-1, PORTEC-2, and PORTEC-3 trials

M.A.D. Haverkort

april 2024

De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1-2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)

A.H. Westenberg

maart 2024

Prognostic significance of MRI-detected extramural venous invasion according to grade and response to neo-adjuvant treatment in locally advanced rectal cancer A national cohort study after radiologic training and reassessment

Dutch Snapshot Research Group

maart 2024

Multileaf collimator characterization and modeling for a 1.5 T MR-linac using static synchronous and asynchronous sweeping gaps

K. Surmann

dr. ir. D. Schuring

dr. ir. A.W.H. Minken

dr. ir. R.G.J. Kierkels

G.C. Hilgers

maart 2024

Quality of life and clinical outcomes in rectal cancer patients treated on a 1.5T MR-Linac within the MOMENTUM study

dr. M.D. den Hartogh

maart 2024

Health-related quality of life in men with oligometastatic prostate cancer following metastases-directed stereotactic body radiotherapy: Real-world data from the E2-RADIatE OligoCare cohort

dr. P.M. Jeene

maart 2024

Molecular and Clinicopathologic Characterization of Mismatch Repair-Deficient Endometrial Carcinoma Not Related to MLH1 Promoter Hypermethylation

M.A.D. Haverkort

februari 2024

Improved delineation with diffusion weighted imaging for laryngeal and hypopharyngeal tumors validated with pathology

J. Lodeweges

februari 2024

Abandonment of Routine Radiotherapy for Nonlocally Advanced Rectal Cancer and Oncological Outcomes

Dutch Snapshot Research Group

februari 2024

Value of Size and Malignant Features of Lateral Lymph Nodes in Risk Stratification at Lateral Local Recurrence of Rectal Cancer: A National Cohort Study

Dutch Snapshot Research Group

februari 2024

Pretrial Quality Assurance for Hypofractionated Salvage Radiation Therapy After Prostatectomy in the Multi-Institutional PERYTON-trial

M.A.D. Haverkort

februari 2024

Doxorubicin Exposure and Breast Cancer Risk in Survivors of Adolescent and Adult Hodgkin Lymphoma

dr. K. Muller

februari 2024

Quality assurance of radiation therapy after breast-conserving surgery among patients in the BOOG 2013-08 trial

A.H. Westenberg

februari 2024

Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma

dr. K. Muller

E.C. Schimmel

januari 2024

Prognostic Implications of Lateral Lymph Nodes in Rectal Cancer: A Population-Based Cross-sectional Study With Standardized Radiological Evaluation After Dedicated Training

Dutch Snapshot Research Group

januari 2024

Survey on fan-beam computed tomography for radiotherapy: Current implementation and future perspectives of motion management and surface guidance devices

G.C. Hilgers

januari 2024

Survey on fan-beam computed tomography for radiotherapy: Imaging for dose calculation and delineation

G.C. Hilgers

januari 2024

Characterization of the on-board megavoltage imager in a magnetic resonance-guided radiotherapy machine for beam output checks

dr. ir. D. Schuring

dr. ir. A.W.H. Minken

G.C. Hilgers

M. Ikink

I. Potters

januari 2024

Editorial: Focal (salvage) treatment for prostate cancer

dr. M. Peters